Cargando…

1-C Metabolism—Serine, Glycine, Folates—In Acute Myeloid Leukemia

Metabolic reprogramming contributes to tumor development and introduces metabolic liabilities that can be exploited to treat cancer. Studies in hematological malignancies have shown alterations in fatty acid, folate, and amino acid metabolism pathways in cancer cells. One-carbon (1-C) metabolism is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmood, Kanwal, Emadi, Ashkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996867/ https://www.ncbi.nlm.nih.gov/pubmed/33652666 http://dx.doi.org/10.3390/ph14030190

Ejemplares similares

Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine
por: Bollino, Dominique, et al.
Publicado: (2022)

Serine and glycine metabolism in cancer()
por: Amelio, Ivano, et al.
Publicado: (2014)

Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells
por: Tedeschi, P M, et al.
Publicado: (2013)

Linking Serine/Glycine Metabolism to Radiotherapy Resistance
por: Sánchez-Castillo, Anaís, et al.
Publicado: (2021)

Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells
por: Kampen, Kim R., et al.
Publicado: (2019)

Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics
por: Lee, Michelle H., et al.
Publicado: (2019)

Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers
por: Sun, Wei, et al.
Publicado: (2023)

Serine–glycine-one-carbon metabolism: vulnerabilities in MYCN-amplified neuroblastoma
por: Zhao, Erhu, et al.
Publicado: (2020)

Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia
por: Emadi, Ashkan, et al.
Publicado: (2016)

Serine, glycine and one-carbon metabolism in cancer (Review)
por: Pan, Sijing, et al.
Publicado: (2020)

Impaired folate 1-carbon metabolism causes formate-preventable hydrocephalus in glycine decarboxylase–deficient mice
por: Santos, Chloe, et al.
Publicado: (2020)

The complexity of the serine glycine one-carbon pathway in cancer
por: Reina-Campos, Miguel, et al.
Publicado: (2019)

Metabolic Plasticity of Acute Myeloid Leukemia
por: Kreitz, Johanna, et al.
Publicado: (2019)

Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study
por: Corley, Elizabeth M., et al.
Publicado: (2022)

Glycine, serine and threonine metabolism confounds efficacy of complement-mediated killing
por: Cheng, Zhi-xue, et al.
Publicado: (2019)

Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
por: Castro, Isabel, et al.
Publicado: (2019)

Glycine and Folate Ameliorate Models of Congenital Sideroblastic Anemia
por: Fernández-Murray, J. Pedro, et al.
Publicado: (2016)

Aspects of Weak Interactions between Folate and Glycine Betaine
por: Bhojane, Purva P., et al.
Publicado: (2016)

Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target
por: Holtzman, Noa G., et al.
Publicado: (2021)

Phosphatases of regenerating liver are key regulators of metabolism in cancer cells – role of Serine/Glycine metabolism
por: Abdollahi, Pegah, et al.
Publicado: (2022)

Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy
por: Tajan, Mylène, et al.
Publicado: (2021)

Differential Expression of Enzymes Associated with Serine/Glycine Metabolism in Different Breast Cancer Subtypes
por: Kim, Sang Kyum, et al.
Publicado: (2014)

Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype
por: Sun, Woo Young, et al.
Publicado: (2016)

Bioinformatics analysis of the serine and glycine pathway in cancer cells
por: Antonov, Alexey, et al.
Publicado: (2014)

Sensitisation of cancer cells to radiotherapy by serine and glycine starvation
por: Falcone, Mattia, et al.
Publicado: (2022)

Mitochondrial metabolism as a target for acute myeloid leukemia treatment
por: Panina, Svetlana B., et al.
Publicado: (2021)

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
por: Stuani, Lucille, et al.
Publicado: (2019)

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
por: Zarka, Jabra, et al.
Publicado: (2020)

Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021)

Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia
por: Sharma, Priyanka, et al.
Publicado: (2023)

Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy
por: Kadia, Tapan Mahendra, et al.
Publicado: (2019)

Exploiting tumour addiction with a serine and glycine-free diet
por: Amelio, Ivano, et al.
Publicado: (2017)

Targeting CLL-1 for acute myeloid leukemia therapy
por: Ma, Hongbing, et al.
Publicado: (2019)

Classification of acute myeloid leukemia
por: Hwang, Sang Mee
Publicado: (2020)

Emerging Immunotherapy for Acute Myeloid Leukemia
por: Tabata, Rikako, et al.
Publicado: (2021)

Chromosomal Instability in Acute Myeloid Leukemia
por: de Oliveira Lisboa, Mateus, et al.
Publicado: (2021)

RSK Isoforms in Acute Myeloid Leukemia
por: Youn, Minyoung, et al.
Publicado: (2021)

Circular RNAs in acute myeloid leukemia
por: Singh, Vijendra, et al.
Publicado: (2021)

Tipifarnib in the treatment of acute myeloid leukemia
por: Thomas, Xavier, et al.
Publicado: (2007)

Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dk551dk34rhna21eiisjsvgrfr